Luc Mainville

All filings by Luc Mainville on record concern Valeo Pharma Inc. We count 37 filings; the first trade dates from 27 December 2018 and the latest from 25 September 2023.

Every open-market trade on record is a purchase: 29 purchases worth €288k, and no sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 1 share grant. So far in 2023, the count stands at 1 purchase and no sales.

A typical purchase (the median) is worth €3,642. No cluster: in 29 purchases, no other insider of the company bought within 30 days.

Most recently, on 28 September 2023, the filings show a transaction in Valeo Pharma Inc. The clock since the last published purchase (18 August 2023) now reads 1,163 days. Between a trade and the moment it shows up on SEDI, the median delay is 1 day. The shorter that gap, the sooner other investors can see what insiders have done. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.